Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of cefepime + AAI101 in hospitalized adults with complicated urinary tract infection
2016-005161-31Phase 2Completed
- Sponsor
- Allecra Therapeutics
- Start
- Apr 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefepime, enmetazobactam in complicated urinary tract infection (cUTI), acute pyelonephritis, bacterial disease, sponsored by Allecra Therapeutics. Started Apr 2017; status: completed.
02
Drugs
cefepimeenmetazobactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritisbacterial disease
Beyond the preview
Go deeper on 2016-005161-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005161-31.